Advertisement
Johnson & Johnson
Subscribe to Johnson & Johnson

The Lead

Designing a Smarter Trial, Earlier

January 21, 2015 1:58 pm | by Vicki Anastasi, VP and Global Head of Medical Device and Diagnostics Research, ICON | Blogs | Comments

Increased regulatory and reimbursement burden has made development timelines longer than ever. As regulators and payers demand more evidence to demonstrate safety, efficacy, and value, manufacturers must design smarter trials that collect...

Device Market Reaches $361 Billion in 2014

December 23, 2014 10:12 am | by Kalorama Information | News | Comments

The global market for medical devices was estimated to reach 361 billion dollars by year’s end....

Cancer Device Gets Stronger Warning from FDA

November 24, 2014 11:58 am | by The Associated Press | News | Comments

U.S. regulators have strengthened their warning against use of a once-popular device for...

Hybrid Anchor Technology Offers Unique Solution for Arthroscopic Surgery

November 10, 2014 9:16 am | by DePuy Synthes | News | Comments

The DePuy Synthes Companies of Johnson & Johnson has launched GRYPHON Anchors with PROKNOT...

View Sample

FREE Email Newsletter

Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures

September 19, 2014 3:40 pm | by DePuy Synthes | News | Comments

DePuy Synthes Companies of Johnson & Johnson launched two new variable angle plating systems featuring its proprietary variable angle locking technology. With this technology, surgeons can adapt screw trajectory to match patient anatomy and...

J&J's Ethicon Loses Another Mesh Trial

September 9, 2014 9:11 am | by PR Newswire | News | Comments

Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Federal Jury in West Virginia awarded a husband and wife $3.27MM in damages, according to Bloomberg News, against Ethicon, Johnson & Johnson's mesh product division...

ETHICON Features Three New Devices for Bariatric Surgery at IFSO 2014

August 26, 2014 1:10 pm | by Ethicon, Inc. | News | Comments

Ethicon is introducing three new endocutter and energy products designed to help address the unique challenges of bariatric procedures such as sleeve gastrectomy and gastric bypass. The announcement was made today at the 19th World...

Advertisement

Codman Neuro Launches New Envoy Guiding Catheters

August 5, 2014 2:59 pm | by Codman Neuro | News | Comments

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of the ENVOY DA XB Distal Access Guiding Catheter and the 7F ENVOY Guiding Catheter for neurovascular procedures. The announcement was made at...

Ortho-Clinical Diagnostics Becomes an Independent, Stand-Alone Company

July 8, 2014 8:58 am | by The Associated Press | News | Comments

Ortho-Clinical Diagnostics, Inc. (OCD) unveiled its newly expanded executive leadership team following the acquisition of the company by The Carlyle Group from Johnson & Johnson. In his first act as OCD Chairman and Chief Executive Officer...

Advanced Wound Care Products Market Nears 19 Billion

June 26, 2014 2:14 pm | by Kalorama Information | News | Comments

According to Kalorama Information, the worldwide wound care market reached revenues of $18,851.0 million in 2013. The healthcare market research publisher says that represents growth of 6% from the previous year. Revenues were based on sales...

Covidien Files Patent Infringement Lawsuit over Ethicon's Ultrasonic Surgical Devices

June 24, 2014 10:07 am | by Business Wire | News | Comments

Covidien has announced that it filed a lawsuit in the U.S. District Court for the District of Connecticut against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company. The lawsuit alleges that Ethicon’s latest ultrasonic surgical...

Medtech Innovator 2014 Winner Announced

June 19, 2014 10:38 am | by RCT Ventures | News | Comments

267 companies submitted their plans. A panel of investor judges reviewed the entries to select the MedTech Innovator Top 10 Semi-Finalists. The investor judges included Christopher P. Martin, President, RCT Ventures; Ned Scheetz, Founder...

Advertisement

Tax Savings Not Only Benefit to Medtronic-Covidien Deal

June 18, 2014 3:53 pm | by Kalorama | News | Comments

U.S.-based Medtronic said it would purchase Ireland-based Covidien for $42.9 billion, combining two of the world’s biggest medical device makers and helping Medtronic savings with a headquarters change. Kalorama estimates the deal will come...

J&J to Grow Device Business, Focus on Emerging Markets

May 23, 2014 12:03 pm | by PR Newswire | News | Comments

At a meeting with members of the investment community, senior leaders from the Medical Devices and Diagnostics (MD&D) segment of Johnson & Johnson outlined plans to improve patient outcomes and expand their market leadership through...

J&J Halts Sale of Electric Fibroid Removal Devices

April 30, 2014 12:36 pm | by The Associated Press | News | Comments

Johnson & Johnson is halting sales of devices used to remove growths in the uterus following a government warning that the electronic surgical tools can inadvertently spread cancer to other parts of the body. The announcement comes one...

J&J: Business Doing Well on New Product Approvals

April 24, 2014 2:32 pm | by Linda A. Johnson - AP Business Writer | News | Comments

Johnson & Johnson CEO Alex Gorsky said Thursday that all three of its business segments are doing well and made significant medical advances last year. Gorsky told about 1,650 shareholders at J&J's annual meeting that the company is...

Plates Give Surgeon Customized Design

April 21, 2014 10:53 am | by DePuy Synthes CMF | News | Comments

DePuy Synthes CMF (Craniomaxillofacial), a leader in skeletal and soft tissue repair and reconstruction and part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of Patient Specific Plates for Mandible (PSPM)...

Advertisement

New Anspach High Speed Drill System Debuts at AANS Annual Meeting

April 9, 2014 10:46 am | by DePuy Synthes Power Tools | News | Comments

DePuy Synthes Power Tools* announced the global launch of the Anspach EG1 High Speed Electric System, a next generation high-speed electric drill with multiple attachments and accessories, designed for use in neurosurgery, otology and spinal...

Transvaginal Mesh Patient Awarded $1.2 Million in Ethicon Mesh Lawsuit, Announces Baron and Budd

April 4, 2014 11:44 am | by The Associated Press | News | Comments

A Dallas jury found transvaginal mesh manufacturer Ethicon and its parent company Johnson & Johnson liable for defects associated with the company’s TVT-O transvaginal mesh sling. The mesh patient, Linda Batiste, was awarded $1.2 million...

J&J Accepts $4B Carlyle Offer for Diagnostics Unit

April 2, 2014 11:52 am | by The Associated Press | News | Comments

Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics business. J&J said Monday that the deal for the blood-testing unit should close by mid...

CAN Calls on DoJ to Investigate J&J for Document Destruction

March 28, 2014 10:17 am | by Corporate Action Network | News | Comments

The Corporate Action Network (CAN) has filed a complaint with the Department of Justice (DOJ) against Johnson and Johnson and its top executives, including Chairman and CEO Alex Gorsky for destroying documents critical to lawsuits brought...

Another Pelvic Mesh Lawsuit Goes to Trial in W.Va.

February 14, 2014 10:50 am | by The Associated Press | News | Comments

Another lawsuit involving pelvic mesh has gone to trial in West Virginia. Media outlets report that jury selection began Monday in U.S. District Court in Charleston. A dozen plaintiffs filed the lawsuit in Texas in 2012. It is among about...

Depuy Synthes Spine Gains Exclusive Worldwide Rights to Launch Lifenet Health’s New Cellular Allograft Product

February 5, 2014 5:48 pm | by DePuy Synthes Spine | News | Comments

DePuy Synthes Spine and DePuy Synthes Biomaterials, divisions of DePuy Orthopaedics, Inc., announced today they have entered into an exclusive worldwide representative agreement for the marketing and promotion of a new cellular allograft...

Johnson & Johnson's 4Q Profit Rises 19 Percent

January 22, 2014 11:38 am | by Linda A. Johnson, AP Business Writer | News | Comments

Surging sales of Johnson & Johnson's prescription medicines and the rebound of its recall-plagued consumer health business lifted fourth-quarter profit 19 percent. The health care giant also enjoyed a $707 million tax benefit from... 

Johnson & Johnson’s Ortho-Clinical Diagnostics Acquired for $4.15 Billion

January 16, 2014 11:23 am | by Business Wire | News | Comments

Global alternative asset manager The Carlyle Group has agreed to acquire Johnson & Johnson’s Ortho-Clinical Diagnostics (OCD) business, a global provider of solutions for screening, diagnosing, monitoring and confirming diseases, for...

Depuy Synthes Spine Launches New Tissue Implant for Spine Surgery

January 6, 2014 11:12 am | by Depuy Synthes Spine | News | Comments

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced today the U.S. launch of CONFORM SHEET, a hydrated, pliable and totally demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion...

TorkLaw Continuing to Accept DePuy ASR Hip Implant Cases

December 27, 2013 1:35 pm | by PR Newswire | News | Comments

In November 2013, Johnson & Johnson announced that it has agreed to pay at least $2.5 billion to settle nearly 8,000 DePuy Orthopaedics Hip Implant lawsuits which have been filed across the country.  It is estimated by some accounts...

DePuy Synthes Trauma Launches Radial Head Prosthesis System in the U.S.

December 13, 2013 7:15 pm | by PR Newswire | News | Comments

DePuy Synthes Trauma announces that it is launching the new Radial Head Prosthesis System for primary and revision joint replacement of the radial head to restore joint function. The System offers several benefits over current technologies...

FDA Reaches $1.25M Settlement with J&J Unit

December 6, 2013 9:33 am | by The Associated Press | News | Comments

The Food and Drug Administration said Wednesday that it reached a $1.25 million settlement with a division of Johnson & Johnson over allegations that it knowingly shipped faulty sterilization equipment used by hospitals. Under the civil...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading